Walgreen In Talks To Sell Off Its Infusion Services Business

In our opinion, the transaction will not have any material impact on Walgreen's financials and valuation. The Infusion Services business of Walgreen has EBITDA of around $105 million, which accounts for less than 3% of the company's total EBITDA.